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Background. We compared analgesia after intrathecal sufentanil alone, sufentanil with epi-
nephrine 200 mg and sufentanil with clonidine 30 mg in patients after total hip replacement, the
endpoints being onset and duration of action.
Methods. We performed a randomized double-blind study of 45 patients for elective total hip
arthroplasty using continuous spinal anaesthesia. As soon as a pain score higher than 3 on a 10
cm visual analogue scale was reported, sufentanil 7.5 mg alone, sufentanil 7.5 mg + epinephrine
200 mg or sufentanil 7.5 mg + clonidine 30 mg in 2 ml normal saline was given intrathecally. Pain
scores, rescue analgesia (diclofenac and morphine) and adverse effects (respiratory depression,
postoperative nausea and vomiting, itching) were observed for 24 h after surgery.
Results. Time to a pain score of <3 [6 (SD 1) vs 6 (1) vs 5 (1) min], time to the lowest pain
score [7 (2) vs 8 (2) vs 8 (2) min] and time to the ®rst dose of systemic analgesic for a pain
score >3 [281 (36) vs 288 (23) vs 305 (30) min] were similar in all three groups. Adverse effects
and analgesic requirements during the ®rst 24 h were also similar.
Conclusion. After total hip replacement, all three analgesic regimens gave good analgesia with
comparable onset and duration of action, and minor adverse effects.
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Intrathecal (i.t.) opioid analgesia is widely used in labour1 2
and is also used after general surgery.3 4 Spinal lipophilic
opioids, such as fentanyl, sufentanil and nalbuphine,4 5 give
prompt and profound analgesia compared with the slow
onset of action of i.t. morphine.5 I.T. sufentanil provides
nearly instantaneous pain relief, but its duration of action is
relatively short in labour (60±90 min),6 7 whereas the
analgesic effect is longer when this opioid is administered
for postoperative pain relief after total hip replacement (240
min).4
A longer duration of analgesia after i.t. sufentanil would
be useful for patients undergoing orthopaedic surgery. A
longer action might be obtained by adding either epinephr-
ine or clonidine, as found in obstetrics, in which epinephrine
(200 mg)2 and clonidine (30 mg)10 mixed with sufentanil
signi®cantly prolong analgesia.
In this double-blind, randomized study we compared the
speed of onset and duration of action after i.t. administration
of sufentanil 7.5 mg alone and mixed with either epinephrine
200 mg or clonidine 30 mg for postoperative pain relief in
elderly patients undergoing total hip arthroplasty.
Methods
After obtaining institutional ethics committee approval and
informed consent, we studied 45 patients aged more than
70 yr, ASA physical status II±IV, scheduled for elective
total hip replacement. We excluded patients with psychiat-
ric illness, allergy to opiates, the study drugs or local
anaesthetics, severe chronic obstructive respiratory disease
(forced expiratory volume in 1 s <600 ml) or coagulation
disorders. On the basis of previous studies,1 4 8 we expected
analgesia to be prolonged for 60 min, giving a standardized
difference of 1.3. To detect a prolongation in duration of
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60 min, 15 patients per group would be needed for b=0.2
and a=0.05.
All patients were given morphine 0.1 mg kg±1 s.c. 60 min
before the operation, to obviate opioid supplements. These
can be needed during surgery because of the prolonged
lateral decubitus position, which sometimes causes shoulder
pain. In the operating room, an i.v. infusion of lactated
Ringer solution was started through a 17 gauge peripheral
venous catheter. Electrocardiogram, non-invasive arterial
blood pressure and peripheral oxygen saturation were
measured and a urinary catheter was inserted. Continuous
spinal anaesthesia was administered with the patient in the
lateral position, operation side up, at the L2±3 or L3±4
intervertebral space using an 18 gauge Tuohy needle
(epidural miniset), and a 20 gauge catheter was inserted
3±4 cm into the subarachnoid space. Injections of 0.5%
isobaric bupivacaine 2.5 or 5 mg (Carbostesineâ, Astra,
Dietikon, Switzerland) were given as required. Surgery was
performed to a standard plan.
After surgery, the i.t. catheter was ¯ushed with normal
saline 2 ml and left in place. Patients received oxygen by
face mask. In the recovery room, when the pain score on the
operated side was greater than 3/10 on a visual analogue
scale (VAS; 0=no pain at all, 10=unbearable pain), the
patients were randomly allocated (by the closed envelope
technique) to one of the three study groups: group SUF
received sufentanil 7.5 mg (Sufentaâ, Janssen-Cilaf, Baar,
Switzerland) alone, group SUF+EPI received sufentanil
7.5 mg with epinephrine 200 mg, and group SUF+CLO
received sufentanil 7.5 mg with clonidine 30 mg, all in
normal saline 2 ml through the i.t. catheter over 30 s. Study
drugs were prepared by an anaesthetist who was the only
person with access to the randomization list and was not
otherwise involved in the study. The ®rst author (RF)
injected drugs blindly and tested the patients during the ®rst
hour. Afterwards, the patients were tested by the nurse in
charge and, after leaving the recovery room, by ward nurses,
who collected the data and gave the analgesics according to
the study plan. Twenty-four hours after the i.t. opioid
injection, one of the authors (RF or ZG) collated the data.
Pain score, sedation score (1=awake and alert; 2=awake
but drowsy, responding to a verbal stimulus; 3=drowsy but
rousable, responding to a physical stimulus; 4=unrousable,
not responding to a physical stimulus), respiratory rate,
oxygen saturation and haemodynamic changes were meas-
ured at i.t. injection and then every 2.5 min for the ®rst
15 min, every 5 min for the next 45 min and every hour for
the next 5 h. We noted times to VAS <3 (onset of action), to
the lowest VAS and to the ®rst systemic analgesic
intervention (reappearance of hip pain, VAS >3) and
recorded ketorolac (Toradolâ, Roche, Reinach,
Switzerland) and morphine requirements (rescue analgesia
given by the systemic route) during the ®rst 24 h after i.t.
injection. We recorded side-effects of nausea and/or
vomiting, pruritus (grade 1=mild, not disturbing; grade
2=moderate, disturbing but not requiring treatment; grade
3=severe, requiring treatment) and respiratory depression
(respiratory rate < 8/min).
Patients could request systemic rescue analgesia if their
pain score was still greater than 3/10 30 min after i.t.
injection or after the i.t. analgesia regressed. Ketorolac
30 mg i.v. was available ®rst, followed by morphine
0.1 mg kg±1 s.c. if the VAS was still greater than 3/10 after
30 min. Afterwards, these analgesics were given on demand
(pain score >3) with a maximum of three doses per 24 h for
ketorolac and eight doses per 24 h for morphine.
Nausea and/or vomiting were treated with metoclopra-
mide (Primperanâ, SyntheÂlabo, Lausanne, Switzerland)
10 mg i.v. and a reduction in mean arterial blood pressure
(MAP) by more than 20% of resting value with ephedrine
5 mg i.v. and a rapid infusion of normal saline 250 ml.
Clemastine (Tavegilâ, Novartis, Bern, Switzerland) 2 mg
i.v. was administered for severe pruritus and naloxone
(Narcanâ, Dupont Pharma, Bad Homburg, Germany) 40 mg
i.v. was injected for respiratory depression (respiratory rate
<8 b.p.m.). The patients only left the recovery room for the
ward after receiving the ®rst rescue analgesia.
Statistical analysis
Data are presented as mean (SD) or median (range) and
groups were compared by analysis of variance or the
Kruskal±Wallis test as required; a P value of less than 0.05
was considered statistically signi®cant.
Results
Patient characteristics, presented in Table 1, were compar-
able between groups. No supplementary i.v. opiates or
sedatives were administered during surgery.
Pain scores, onset and duration of action of i.t. sufentanil
alone and with epinephrine or clonidine are presented in
Table 2 and Figures 1 and 2. Results were comparable in the
three groups. After i.t. injection, all patients achieved a VAS
of 0 (Table 2).
Although a slightly shorter onset and longer duration of
action was observed with the sufentanil±clonidine mixture,
the differences were not statistically signi®cant (Figs 1
and 2).
Table 1 Patient characteristics [mean (SD or range), n=15 for each group].
ASA, American Society of Anesthesiologists; SUF, sufentanil; SUF+EPI,
sufentanil plus epinephrine; SUF+CLO, sufentanil plus clonidine
SUF SUF + EPI SUF+CLO
Age (yr) 76 (70±82) 79 (73±85) 78 (71±85)
Height (cm) 167 (8) 163 (10) 166 (8)
Weight (kg) 75 (11) 71 (15) 78 (15)
Females, males 5, 10 10, 5 6, 9
ASA class 2, 3, 4 3, 12, 0 5, 10, 0 4, 11, 0
Intrathecal sufentanil with epinephrine or clonidine
563
The analgesic requirements in the ®rst 24 h were similar
(Table 3). One patient in the SUF group, two in the
SUF+EPI group and two in the SUF+CLO group were not
considered for analysis of postoperative analgesic require-
ments because they received further i.t. analgesia.
The cardiovascular changes in the ®rst hour after i.t.
injection were comparable in all groups (Table 4).
Ephedrine was given to one patient in the SUF group, two
patients in the SUF+EPI group and four patients in the
SUF+CLO group.
Respiratory rates less than 8 b.p.m. were not seen.
However, one patient in the SUF+EPI group had an oxygen
saturation less than 95% for a short time, requiring
adjustment of oxygen administration. Four patients in the
SUF group, six in the SUF+EPI group and eight in the
SUF+CLO group complained of pruritus in the ®rst hour
after i.t. injection. Antihistamines were required in two
patients in each of the SUF and SUF+EPI groups and in one
patient in the SUF+CLO group. Before rescue analgesia,
two patients in the SUF group, four in the SUF+EPI group
and one in the SUF+CLO group had nausea and/or vomiting
requiring antiemetic therapy. Sedation score never exceeded
grade 2 in any patients in the ®rst hour after i.t. injection.
Discussion
We believe this is the ®rst study of analgesia from
sufentanil±epinephrine and sufentanil±clonidine combin-
ations for postoperative pain relief in patients, apart from
obstetrics. All the treatment gave, within 5±6 min, excellent
pain relief which lasted for 4.5±5 h. No signi®cant
differences between groups were found in the quality of
pain relief assessed by VAS pain scores, onset or duration of
analgesic action, adverse effects and subsequent analgesic
treatment.
We added epinephrine 200 mg to sufentanil, as this dose is
commonly used in obstetrics without circulatory effects.2 6 8
Cardiovascular effects of i.t. clonidine are a serious concern,
and in our frail, elderly patients we gave a moderate dose of
30 mg, which seems to prolong the analgesic action of i.t.
sufentanil in labour and to have acceptable effects on the
circulation.1
The prolongation of analgesia by epinephrine has in the
past been attributed to vasoconstriction, reducing the
clearance of coadministered drugs from the subarachnoid
space.9 However, epinephrine does not reduce the maximal
plasma concentration of local anaesthetics.10 11 An alterna-
tive explanation for the prolongation of spinal anaesthesia
by vasoconstrictors may be a direct effect on the nociceptive
system in the dorsal horn of the spinal cord,12 where opioids
and adrenergic agonists may interact. In cats, the suppres-
sion of nociception by fentanyl is increased by epinephr-
ine.12 In humans, the effects of epinephrine in addition to i.t.
sufentanil, which have been only described in labour, are
controversial. A study8 of sufentanil 10 mg i.t. with or
without epinephrine 200 mg reported a signi®cant but small
prolongation of analgesia from 115 to 132 min, and another
Table 2 Pain scores (10-point VAS scale), onset and duration of action in
the three groups [mean (SD) or median (range), n=15 for each group]. SUF,
sufentanil; SUF+EPI, sufentanil plus epinephrine; SUF+CLO, sufentanil plus
clonidine
SUF SUF+EPI SUF+CLO
Pain score before injection 5 (4±8) 5 (4±10) 5 (4±9)
Time to pain score <3 (min) 6 (1) 6 (1) 5 (1)
Time to lowest pain score (min) 7 (2) 8 (2) 8 (2)
Time to ®rst systemic analgesic
intervention (min)
281 (36) 288 (23) 305 (30)
Lowest pain score 0 0 0
Pain score at 24 h 0 (0±1) 0 (0±2) 0 (0±2)
Fig 1 Box plots showing the onset of action (time between initial
intrathecal injection and reaching pain score <3) in all groups. Open
boxes represent the 25th to 75th percentiles and contain the median
(horizontal bar) and mean (small square) values; vertical bars represent
the 10th to 90th percentiles.
Fig 2 Box plots showing the duration of action [time from initial
intrathecal injection to reappearance of a pain score (VAS) of >3,
requiring the ®rst systemic analgesic intervention] in all groups. Open
boxes represent the 25th to 75th percentiles and contain the median
(horizontal bar) and mean (small square) values; vertical bars represent
the 10th to 90th percentiles.
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showed pain relief for 90 min in both groups.6 Our data
support this ®nding. Two other studies in labour suggest a
more pronounced effect of epinephrine added to a mixture
of bupivacaine and sufentanil. Gautier and colleagues13
found that a small dose of epinephrine (25 mg) added to
bupivacaine 1 mg and sufentanil 5 mg i.t. prolonged the
analgesia by about 40 min. Campbell and colleagues2 added
a larger dose of epinephrine 200 mg to sufentanil 10 mg and
bupivacaine 2.5 mg, and reported a prolongation of 43 min.
Adding epinephrine to a mixture of local anaesthetic and
opioids seems more ef®cient in prolonging analgesia than
adding it to sufentanil alone, and the reason for this is not
clear.
We found only a trend to prolongation of pain relief in the
SUF+CLO group compared with the control SUF group
(305 vs 281 min), whereas the addition of clonidine 30 mg to
sufentanil 5 mg prolonged labour analgesia from 99 to
145 min1 and from 97 to 125 min.14 These differences may
be related to the different type of pain, with an increasing
and changing pattern during labour (somatic to visceral)
compared with postoperative pain, which tends to decrease
with time. Compared with labour analgesia, the pain relief
in our elderly patients lasted 281 (36) min and the addition
of clonidine 30 mg was probably not enough to improve the
analgesia provided by sufentanil 7.5 mg alone. A larger dose
of clonidine, e.g. 50 mg, might have provided a longer
duration of pain relief, as demonstrated by d'Angelo and
colleagues,15 who found labour analgesia lasting 197 min
after adding clonidine 50 mg to sufentanil 7.5 mg and
bupivacaine 2.5 mg, and 132 min for sufentanil±-
bupivacaine.
Clonidine extends labour analgesia when added to i.t.
opioids, but causes hypotension.1 13 14 16 17 The incidence of
hypotension was doubled by adding clonidine 30 mg to
sufentanil 5 mg (25 vs 50%).1 Mercier and colleagues found
that 63% of patients developed hypotension with the same
analgesic regimen.14 Sia reported a decrease in blood
pressure in 60% of parturients receiving bupivacaine
1.25 mg, sufentanil 5 mg and clonidine 30 mg compared
with only 7% in a control group without clonidine.16 We
found a maximal decrease in MAP, from the baseline value,
of 22 and 23% in the SUF+EPI and SUF+CLO groups
respectively, compared with 14% in the SUF control group
(Table 4). The trend towards greater hypotension in the
SUF+CLO group is not surprising,1 14 but a 22% decrease in
blood pressure after adding epinephrine has not been
described previously. Apart from profound analgesia redu-
cing sympathetic activity, no other explanation is evident.
The number of patients in this study may have been
insuf®cient to detect other cardiovascular effects.
Pruritus was noted in 40% (18 out of 45 patients), with no
differences between the groups. Severe itching requiring
antihistamines occurred in ®ve patients (11%).
These data are consistent with our previous report4 and
well below the 80±100% observed in obstetric studies.1 2
Pregnant women may be more susceptible than elderly
patients, possibly for hormonal reasons. Epinephrine did not
decrease the incidence of pruritus in our patients, contrary to
Camman and colleagues' study, in which pruritus was
reduced by 50% in the epinephrine group.6
Postoperative nausea and/or vomiting was not statistic-
ally different between groups. We found no greater
incidence in the SUF+EPI group, in contrast to the ®nding
of Camman and colleagues (0% without epinephrine vs 35%
with epinephrine).6
In conclusion, after total hip replacement, i.t. sufentanil
alone or mixed with epinephrine or clonidine provides
excellent analgesia (a pain score of 0 was achieved in all
patients investigated), with comparable onset and duration
of action. Clonidine and epinephrine tend to decrease blood
pressure, so we do not recommend adding these agents to
sufentanil.
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